金花速溶黑茶对2型糖尿病患者的影响:多中心、开放标签、随机对照试验的研究方案
本研究为在中国三个中心开展的多中心、开放标签、平行随机对照试验,计划纳入264例40-70岁2型糖尿病患者,按1:1随机分为干预组(金花速溶黑茶1克每日三次联合现有口服降糖药)和对照组(温水联合现有口服降糖药),干预12个月。主要结局为6个月时糖化血红蛋白变化,次要结局包括6个月和12个月时的糖尿病缓解率、空腹血糖、餐后2小时血糖、甘油三酯-葡萄糖指数、血压、腹围、体重指数等代谢指标。
要点
- 金花速溶黑茶在体外和动物研究中显示降糖调脂作用,但缺乏稳健临床证据。
- 本研究为首个大规模、长期评估金花黑茶作为2型糖尿病辅助治疗随机对照试验。
- 主要结局为6个月时糖化血红蛋白变化,次要结局覆盖6个月和12个月代谢指标。
核心结论
- 本研究旨在探究金花速溶黑茶对2型糖尿病患者的血糖和血脂调节作用,结果可能支持发酵金花茶在糖尿病管理中的辅助作用,为常规治疗提供补充策略。
研究设计与样本
- 多中心、开放标签、平行随机对照试验,在中国三个中心开展,计划纳入264例40-70岁2型糖尿病患者,排除胃肠道疾病或急性糖尿病相关并发症者。
- 参与者按1:1随机分为干预组(金花速溶黑茶1克每日三次联合现有口服降糖药,干预12个月)和对照组(温水联合现有口服降糖药,无额外积极干预)。
- 主要结局为6个月时糖化血红蛋白变化;次要结局包括6个月和12个月时的糖尿病缓解率、空腹血糖、餐后2小时血糖、甘油三酯-葡萄糖指数、血压、腹围、体重指数及其他代谢参数。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUNDS: The global prevalence of diabetes is rising, with many patients experiencing challenges in medication adherence and adverse effects associated with synthetic drugs. Natural products have attracted interest as potential preventive or adjunctive therapies. Jinhua dark tea (JHTea), a naturally fermented Chinese tea, has shown promising glucose-lowering and lipid-modulating effects in vitro and animal studies, but robust clinical evidence is lacking. This study is the first large-scale, long-term randomized controlled trial (RCT) evaluating JHTea as an adjunctive therapy for type 2 diabetes mellitus (T2DM). METHODS: This multicenter, open-label parallel randomized controlled trial across three centers in China will enroll 264 participants aged 40-70 years with T2DM, excluding those with gastrointestinal diseases or acute diabetes-related complications. Participants will be randomized 1:1 to the following: (1) intervention Group: 1 g of JHTea three times daily plus current oral hypoglycemic agents for 12 months. (2) control Group: warm water plus current oral hypoglycemic agents alone, with no extra active intervention. The primary outcome is the change in hemoglobin A1c (HbA1c) at 6 months. Secondary outcomes at 6 and 12 months include diabetes remission rate, fasting plasma glucose (FPG), 2-h postprandial glucose, triglyceride-glucose index (TyG), blood pressure, abdominal circumference, body mass index (BMI), and other metabolic parameters. DISCUSSION: This study aims to investigate the glycemic and lipid-modulating effects of Jinhua instant dark tea in patients with T2DM. The findings may support the adjunctive role of fermented Jinhua tea in diabetes management, providing a complementary strategy to conventional therapies. TRIAL REGISTRATION: Chinese Clinical Trial Registry ChiCTR2400080339. Registered on 26 January 2024. https://www.chictr.org.cn/showproj.html?proj=214179.
引用
- Chen N, Zhao K, Xu Y, et al. Effects of Jinhua instant dark tea in patients with type 2 diabetes mellitus: study protocol for a multicenter, open-label, randomized controlled trial. Trials. 2025. PMID: 41239421. doi:10.1186/s13063-025-09235-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。